Tal Teitz

Scintillon Institute — United States

Medicine · Health Sciences

21h-index2.5kcitations59works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(21), Cell death mechanisms and regulation(18), Hearing, Cochlea, Tinnitus, Genetics(9), Virus-based gene therapy research(5), CRISPR and Genetic Engineering(5)

Publications59 total

Oral AZD5438 is a clinically translatable otoprotectant against cisplatin-induced hearing loss
Neoplasia·2025Open Access
Oral AZD5438 is a clinically translatable otoprotectant against cisplatin-induced hearing loss
SSRN Electronic Journal·2025Open Access
Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice
Clinical and Translational Medicine·2024· 2 citedOpen Access
ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response
International Journal of Molecular Sciences·2024· 7 citedOpen Access
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss
Pharmaceuticals·2024· 2 citedOpen Access
FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss
2024Open Access
Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice
2024Open Access
KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss
Journal of Neuroscience·2024· 8 citedOpen Access
Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI
Journal of the American Society of Nephrology·2023· 19 citedOpen Access
KSR1 knockout mouse model demonstrates MAPK pathway’s key role in cisplatin- and noise-induced hearing loss
2023· 2 citedOpen Access
Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model
JCI Insight·2023· 13 citedOpen Access
ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response
2023· 8 citedOpen Access
Supplementary Figures 1-5 from Caspase-8 Association with the Focal Adhesion Complex Promotes Tumor Cell Migration and Metastasis
2023Open Access
Data from Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
2023Open Access
Supplementary Table 3 from Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
2023Open Access
Data from Caspase-8 Association with the Focal Adhesion Complex Promotes Tumor Cell Migration and Metastasis
2023Open Access
Supplementary Figures 1-5 from Caspase-8 Association with the Focal Adhesion Complex Promotes Tumor Cell Migration and Metastasis
2023Open Access
Supplementary Table 1 from Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
2023Open Access
Supplementary Table 2 from Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
2023Open Access
Supplementary Figures 1 - 7 from Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Jill M. Lahti(19), Matthew A. Ingersoll(11), Richard D. Lutze(10), Vincent J. Kidd(9), Dwayne G. Stupack(8), Taosheng Chen(7), Jian Zuo(7), Regina G. Kelmann(7), David Mikolon(6), Madoka Inoue(6), Jerold E. Rehg(6), David Finkelstein(6), Christopher Calabrese(6), Marcus B. Valentine(6), Simone Barbero(5), Duane Currier(5), Kejin Zhu(5), Yong‐Dong Wang(5), Marcelo Rubinstein(5), Razqallah Hakem(5)